All Stories

  1. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  2. The burden and trend of diseases and their risk factors in Australia, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  3. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  4. Bridging the Gap in Cancer-Related Stroke Management: Update on Therapeutic and Preventive Approaches
  5. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
  6. An Equity and Justice-Informed Ethical Framework to Guide Incidental Findings in Brain Imaging Research
  7. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
  8. When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer
  9. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
  10. Association of Lesion Topography with Functional Outcomes in Acute Ischemic Stroke Patients Considered for, or Receiving, Reperfusion Therapy: A Meta-Analysis
  11. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  12. Clot Morphology in Acute Ischemic Stroke Decision Making
  13. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  14. COVID-19 and the cardiovascular system-current knowledge and future perspectives
  15. Is Composition of Brain Clot Retrieved by Mechanical Thrombectomy Associated with Stroke Aetiology and Clinical Outcomes in Acute Ischemic Stroke?—A Systematic Review and Meta-Analysis
  16. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  17. Incidental findings in brain imaging research: spotlight on ethical considerations
  18. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  19. Telemedicine during and post-COVID 19: The insights of neurosurgery patients and physicians
  20. Optic nerve infiltration by large B-cell lymphoma
  21. The association of transradial access and transfemoral access with procedural outcomes in acute ischemic stroke patients receiving endovascular thrombectomy: A meta-analysis
  22. Prognostic accuracy and impact of cerebral collateral status on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: a systematic meta-analysis
  23. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
  24. Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis
  25. Incidence of white matter lesions in hospitalised COVID‐19 patients: a meta‐analysis
  26. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  27. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  28. Clinical outcomes following reperfusion therapy in acute ischemic stroke patients with infective endocarditis: a systematic review
  29. Role of Neutrophil-Lymphocyte Ratio in the Prognosis of Acute Ischaemic Stroke After Reperfusion Therapy: A Systematic Review and Meta-analysis
  30. Prognostic Role of the Platelet-Lymphocyte Ratio in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy: A Meta-Analysis
  31. Cardiovascular Complications of COVID-19
  32. Diagnostic and prognostic utility of brain collaterals in acute ischaemic stroke: Current knowledge and insights on treatment decision-making
  33. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  34. Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
  35. Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalised COVID‐19 patients: a systematic review and meta‐analysis
  36. A Multicentre Study Comparing Cerebrovascular Disease Profiles in Pacific Islander and Caucasian Populations Presenting with Stroke and Transient Ischaemic Attack
  37. Brain atrophy in acute ischaemic stroke patients treated with reperfusion therapy: a systematic review
  38. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  39. Stroke Aetiology and Collateral Status in Acute Ischemic Stroke Patients Receiving Reperfusion Therapy—A Meta-Analysis
  40. Creutzfeldt-Jakob Disease in South West Sydney 2014–2020: An Unusually High Incidence of a Rare Disease
  41. Value of pre-intervention CT perfusion imaging in acute ischemic stroke prognosis
  42. Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?
  43. Optimising Prehospital Pathways to Improve Acute Stroke Reperfusion Therapy Delivery: Systems-Based Approaches
  44. In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis
  45. Acute Ischaemic Stroke in Infective Endocarditis: Pathophysiology and Clinical Outcomes in Patients Treated with Reperfusion Therapy
  46. Hypertensive urgencies during the first wave of COVID-19 pandemic in a tertiary hospital setting: A “U” shaped alarming curve.
  47. Digital subtraction angiography in cerebrovascular disease: current practice and perspectives on diagnosis, acute treatment and prognosis
  48. Role of Diabetes in Stroke: Recent Advances in Pathophysiology and Clinical Management
  49. Tracking development assistance for health and for COVID-19
  50. Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis
  51. Value of pre-intervention computed tomography perfusion imaging in the assessment of tissue outcome and long-term clinical prognosis in patients with anterior circulation acute ischemic stroke receiving reperfusion therapy: a systematic review
  52. Measuring routine childhood vaccination coverage in 204 countries and territories
  53. Emerging role of white matter lesions in cerebrovascular disease
  54. Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis
  55. In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis
  56. Hyperdense MCA (HDMCA) sign in acute ischemic stroke patients receiving reperfusion therapy
  57. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
  58. Diagnostic and Prognostic Utility of CT Perfusion Imaging in Posterior Circulation Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
  59. Is COVID-19 Another Case of Obesity Paradox? - Results from An International Ecological Study on behalf of the REPROGRAM Consortium Obesity
  60. Practical Design of Flow Meter for Mechanical Ventilation Equipment
  61. Effect of prehospital workflow optimization on treatment delays and clinical outcomes in acute ischemic stroke: A systematic review and meta‐analysis
  62. Editorial: Telemedicine During and Beyond COVID-19
  63. Telemedicine During and Beyond COVID-19
  64. Call for Action to Address Equity and Justice Divide During COVID-19
  65. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  66. CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis
  67. Addressing the Covid-19 Burden on Medical Education and Training: The Role of Telemedicine and Tele-Education During and Beyond the Pandemic
  68. At the Epicenter of COVID-19–the Tragic Failure of the Global Supply Chain for Medical Supplies
  69. Designing Futuristic Telemedicine Using Artificial Intelligence and Robotics in the COVID-19 Era
  70. Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1)
  71. In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches
  72. Cerebral collaterals in acute ischaemia: Implications for acute ischaemic stroke patients receiving reperfusion therapy
  73. Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2)
  74. Separating posterior-circulation stroke from vestibular neuritis with quantitative vestibular testing
  75. Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
  76. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
  77. Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
  78. Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway
  79. Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study
  80. Hemiprosopometamorphopsia: a Case of Impaired Facial Perception Restricted to the Eye
  81. Impact of obesity-induced type 2 diabetes on long-term outcomes following stroke
  82. Trends in acute stroke presentations to an emergency department: implications for specific communities in accessing acute stroke care services
  83. Clot Histopathology in Ischemic Stroke with Infective Endocarditis
  84. Reperfusion therapy in acute ischemic stroke: dawn of a new era?
  85. Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study
  86. Clarion call for histopathological clot analysis in “cryptogenic” ischemic stroke: implications for diagnosis and treatment
  87. The influence of initial stroke severity on mortality, overall functional outcome and in-hospital placement at 90 days following acute ischemic stroke: A tertiary hospital stroke register study
  88. Association of Cortical Vein Filling with Clot Location and Clinical Outcomes in Acute Ischaemic Stroke Patients
  89. Baseline collateral status and infarct topography in post-ischaemic perilesional hyperperfusion: An arterial spin labelling study
  90. Delay of late-venous phase cortical vein filling in acute ischemic stroke patients: Associations with collateral status
  91. Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging
  92. Cancer stem cells in solid tumors
  93. Towards an Intelligent Wheelchair System for Users With Cerebral Palsy
  94. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging